Vaccine Arrival-to-Campaign Capacity Director

The mandate

Donation offers and manufacturer release schedules arrive according to global supply, while countries plan campaigns around people, storage and local delivery. Several programmes accepted volume using nameplate cold-room capacity even though occupied freezers, carton geometry, conditioning space, diluents, syringes, customs timing and daily administration limited usable throughput. The defined problem is to decide what each country can accept, when and in what sequence, including ultra-low-temperature products, rather than qualify transport providers or remediate 3PL quality.

The deliverable is an arrival-to-campaign capacity book containing four product and storage profiles, eighteen country receiving envelopes, occupied and usable capacity, ultra-low-temperature and dry-ice constraints, import readiness, ancillary-kit coupling, primary-distribution throughput, session demand, expiry exposure and accept, split or defer rules. The WHO 2025 international vaccine-shipping guidance informs the donor-to-country receiving boundary. Carrier procurement, packout qualification, product disposition and immunisation policy are excluded.

Milestone one closes at the end of week two with offered, inbound, stored and planned-dose reconciliation. Milestone two, at week four, delivers eighteen receiving envelopes and four product profiles. Milestone three, at week six, runs three arrival-bank exercises involving concurrent donor offers, delayed customs release and reduced freezer availability. Milestone four, at week eight, submits the accepted capacity book, allocation decision board, country training and twelve-month refresh calendar.

Acceptance requires every country to match an offered dose population to import approval, usable cubic capacity, freezer occupation, conditioning or dry-ice capability, diluent and syringe availability, outbound throughput, booked sessions and remaining shelf life. Three exercises must prevent both avoidable refusal and unusable overdelivery. The council accepts when all eighteen country owners independently reach the same accept, split, defer or substitute decisions and can explain the patient and wastage consequences.

The client will provide allocation offers, release forecasts, product and pack dimensions, storage requirements, inbound plans, country inventories, equipment state, import status, ancillary supplies, distribution capacities, session plans, wastage and expiry records. It will nominate donor and country owners and secure six national-store or campaign reviews. Countries retain acceptance and immunisation decisions; Quality retains product disposition; donors retain allocation; carriers retain safe transport.

Why this is external work

Donor teams see available doses, product teams see storage requirements and countries see local capacity, but no shared model tests whether all three become administered doses before expiry. Programme staff cannot neutrally challenge politically sensitive offers while managing live campaigns. An independent supply architect can expose capacity honestly without representing a manufacturer, carrier or equipment supplier.

What you will own

• Reconcile offered, released, inbound, stored, allocated, administered, wasted and expired dose populations across eighteen programmes.
• Calculate usable receiving envelopes from occupied space, packaging geometry, equipment state, handling flow and contingency reserve.
• Couple each product offer to import readiness, diluents, syringes, distribution lift, trained sites and scheduled campaign demand.
• Design accept, split, defer and substitute rules with decision clocks, evidence owners and patient or wastage consequence.
• Exercise simultaneous arrivals, customs delay and freezer loss without assuming nominal storage or emergency dry ice is available.
• Test six national-store or campaign interfaces and expose stock that is technically stored but operationally stranded.
• Deliver the accepted capacity book, country decision boards, training cases, allocation protocol and twelve-month refresh calendar.

Candidate qualifications

• Designed multi-country vaccine allocation and campaign supply across refrigerated, frozen and ultra-low-temperature products.
• Has deferred or split a politically important donation because usable country capacity and administration demand could not absorb it.
• Understands packaging volume, freezer occupation, dry ice, ancillary kits, import timing, distribution and session throughput together.
• Can distinguish doses available globally, acceptable nationally, physically receivable and realistically administered before expiry.
• Has reconciled donor, manufacturer, national-store and campaign plans without assuming product-disposition or immunisation authority.
• Delivered capacity rules that country teams maintained through changing offers, equipment outages and seasonal campaign demand.

Non-negotiables

• Can complete six national-store, campaign or allocation reviews inside the eight-week engagement.
• Will remain independent of vaccine manufacturers, carriers, cold-equipment vendors, donors and implementation contractors.
• Accepts country, donor, Quality, customs, carrier and immunisation-policy authority boundaries throughout the work.
• Brings multi-country vaccine arrival and campaign planning; transport-lane qualification alone is insufficient.

1. 49 words maximum. Describe a vaccine offer you split or deferred because nominal storage overstated usable campaign capacity.
2. 49 words maximum. How would you quantify doses physically stored but operationally stranded before administration?
3. 49 words maximum. Which ancillary constraint should change an otherwise attractive donor allocation first?